- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02903758
Frequency and Distribution of Mixed Falciparum-vivax Infections in French Guiana (MixMal)
September 13, 2016 updated by: Centre Hospitalier de Cayenne
Malaria is still endemic in the interior of French Guiana.
mixed infections by 2 or more different malaria parasites lead to complex and potentially harmfull therapeutic problems.
The aim of the study was to look at malaria smears between 2000 and 2008 and determine using PCR the frequency of mixed infections, and their distribution in the terrtory of French Guiana.
Overall 10.75% of 400 smears showed mixed infection with P. falciparum and P. vivax.
The Maroni river where Duffy negative populations live was largely devoid of vivax infections.
These results suggest that mixed infections are frequent in french guiana except on the Maroni river which leads to practical implications for clinicians facing a patient with clinical malaria.
Study Overview
Study Type
Observational
Enrollment (Actual)
400
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
French Guiana
-
Cayenne, French Guiana, France, 97306
- Centre Hospitalier de Cayenne
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
malaria positive patients
Description
Inclusion Criteria:
- malaria diagnosis
Exclusion Criteria:
- no malaria
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
malaria
Time Frame: At the time of diagnosis of malaria
|
PCR positive for malaria parasites
|
At the time of diagnosis of malaria
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2000
Primary Completion (Actual)
January 1, 2000
Study Completion (Actual)
December 1, 2008
Study Registration Dates
First Submitted
September 6, 2016
First Submitted That Met QC Criteria
September 13, 2016
First Posted (Estimate)
September 16, 2016
Study Record Updates
Last Update Posted (Estimate)
September 16, 2016
Last Update Submitted That Met QC Criteria
September 13, 2016
Last Verified
September 1, 2016
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- mixmalaria
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.